Stanhope and Mitsui signs up pharma company at White City Place


Stanhope, Mitsui Fudosan and AIMCo have signed Autolus to become the first major life sciences company to take space at White City Place.

Autolus, a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, will initially be taking the fifth floor of the MediaWorks building with approximately 33,000 sq ft of office and lab space and is due to occupy the building in October 2018.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article

Registration includes the following benefits:

  • Access up to four FREE articles per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Four articles not enough? SUBSCRIBE for unlimited access to over 100 weekly articles and our comprehensive archive. For as little as £5 per week.

Registered users and subscribers SIGN IN here to continue